查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601142

器官移植市場：按類型、最終用戶分類 - 2025-2030 年全球預測

Organ Transplantation Market by Type (Heart Transplantation, Kidney Transplantation, Liver Transplantation), End User (Hospitals & Care Providers, Transplant Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年器官移植市值為164.5億美元，預計2024年將達到180.7億美元，複合年成長率為10.30%，到2030年將達到326.9億美元。

器官移植市場的範圍和定義包括將器官從體內取出並移植到接受者體內的外科手術。由於糖尿病、心臟病和腎臟病等慢性疾病的增加，對器官移植的需求不斷增加。應用包括心臟移植、肝臟移植、腎臟移植、肺移植和胰臟移植，最終用途包括醫院、移植中心和研究機構。該市場受到器官衰竭盛行率增加、手術技術進步、免疫抑制藥物改進以及對器官捐贈的認知和承諾不斷增強等因素的顯著影響。

主要市場統計
基準年[2023] 164.5億美元
預測年份 [2024] 180.7億美元
預測年份 [2030] 326.9億美元
複合年成長率（%） 10.30%

最新的潛在機會來自生物工程和再生醫學等技術進步，這些技術進步解決了器官供不應求和排斥併發症的限制。器官保存技術的創新和人造器官的開發代表了一條利潤豐厚的前進道路。不斷成長的市場面臨器官排斥風險、倫理問題、高成本和嚴格的法律規範等限制，這些仍然是挑戰。此外，器官供需之間的差距繼續阻礙市場擴張。

為了利用成長機會，相關人員應專注於異種移植和幹細胞治療的創新研究，這有可能擴大器官供應。促進器官捐贈登記和公共教育宣傳活動可以提高捐贈率並進一步支持市場開拓。此外，探索個人化醫療來調整免疫抑制方案可以提高移植成功率。畢竟，市場動態是動態的，不斷的研究和創新努力可以解決器官短缺問題並改善患者的治療結果，從而推動市場的發展。

市場動態：揭示快速發展的器官移植市場的關鍵市場洞察

供需的動態交互作用正在改變器官移植市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 器官移植手術數量增加
    • 慢性疾病增加和器官衰竭加速
    • 開拓器官捐贈與移植合法化管道
  • 市場限制因素
    • 器官捐贈者短缺和治療費用上漲
  • 市場機會
    • 器官移植方法的技術進步
    • 器官捐贈意識不斷增強
  • 市場問題
    • 器官移植的社會與倫理問題

波特五力：駕馭器官移植市場的策略工具

波特的五力框架是了解器官移植市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解器官移植市場的外部影響

外部宏觀環境因素在塑造器官移植市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解器官移植市場的競爭狀況

器官移植市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：器官移植市場供應商績效評估

FPNV定位矩陣是評估器官移植市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 器官移植手術數量增加
      • 慢性疾病和器官衰竭的增加
      • 開拓器官捐贈與移植的合法管道
    • 抑制因素
      • 器官捐贈者短缺和治療費用上漲
    • 機會
      • 器官移植技術的技術進步
      • 意識提升
    • 任務
      • 器官移植的社會與倫理問題
  • 市場區隔分析
    • 類型：由於腎臟疾病增加導致腎臟移植迅速增加
    • 最終用戶：人員和技術的專業化推動移植中心的器官移植
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境
  • 客戶客製化

第6章 器官移植市場：依類型

  • 介紹
  • 心臟移植
  • 腎臟移植
  • 肝臟移植
  • 肺移植
  • 胰臟移植

第7章 器官移植市場：依最終使用者分類

  • 介紹
  • 醫院和護理提供者
  • 移植中心

第8章美洲器官移植市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太器官移植市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲器官移植市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • TransMedics 簽署收購 Summit Aviation 的最終協議，擴大 TransMedics 器官移植航空能力
    • LiveOnNY 和 MediGO 合作推出即時器官追蹤技術，提高器官捐贈和移植生態系統的透明度和課責
    • 泛美衛生組織和西班牙簽署協議加強美洲器官捐贈和移植

公司名單

  • Illumina, Inc.
  • Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • Artivion, Inc.
  • Thermo Fisher Scientific Inc.
  • Pfizer Inc.
  • OrganOx Limited
  • Organovo Holdings, Inc.
  • Arthrex, Inc.
  • 21st Century Medicine
  • Exactech, Inc.
  • CHIESI Farmaceutici SpA by Amryt Pharma PLC
  • Xvivo Perfusion AB
  • Sanofi SA
  • BiolifeSolutions, Inc.
  • Dr. Franz Kohler Chemie GmbH
  • Teva Pharmaceuticals Industries Ltd.
  • Preservation Solutions, Inc.
  • F. Hoffmann-La Roche Ltd
  • Organ Recovery Systems
  • Medtronic PLC
  • Astellas Pharma Inc.
  • Stryker Corporation
  • Novartis AG
  • NHS Blood and Transplant
  • TransMedics Group, Inc.
  • Plexision
  • AbbVie Inc.
  • Bio-Rad Laboratories, Inc.
Product Code: MRR-437896AA3BAA

The Organ Transplantation Market was valued at USD 16.45 billion in 2023, expected to reach USD 18.07 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 32.69 billion by 2030.

The scope and definition of the organ transplantation market encompass the surgical procedure where an organ is removed from one body and placed in the body of a recipient, often necessitated by the failure or non-functionality of the recipient's organ. The necessity of organ transplantation is increasingly critical due to rising incidences of chronic diseases like diabetes, heart disease, and kidney disorders, which often require such interventions. Application-wise, it spans heart, liver, kidney, lung, and pancreas transplants, with end-use scope including hospitals, transplant centers, and research organizations. The market is significantly influenced by factors such as the growing prevalence of organ failure, advancements in surgical techniques, improved immunosuppressive drugs, and increasing awareness and initiatives towards organ donation.

KEY MARKET STATISTICS
Base Year [2023] USD 16.45 billion
Estimated Year [2024] USD 18.07 billion
Forecast Year [2030] USD 32.69 billion
CAGR (%) 10.30%

Latest potential opportunities arise from technological advancements like bioengineering and regenerative medicine, addressing the limitations posed by organ supply shortages and rejection complications. Innovation in organ preservation techniques and development of artificial organs offers lucrative avenues. Despite the growth prospects, the market faces limitations such as organ rejection risks, ethical concerns, high costs, and stringent regulatory frameworks, which remain challenging factors. Furthermore, the disparity between organ demand and supply continues to hinder market expansion.

To harness growth opportunities, stakeholders should focus on innovative research in xenotransplantation and stem cell therapy, which hold promise for extending the organ supply. Advancing organ donor registration systems and public education campaigns can stimulate donor rates, further supporting market development. Additionally, exploring personalized medicine to tailor immunosuppressive regimens can enhance transplantation success rates. Ultimately, the organ transplantation market is dynamic and driven by continuous research and innovation efforts to address organ scarcity and enhance patient outcomes, indicating a significant potential for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplantation Market

The Organ Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Number of Organ Transplantation Surgeries
    • Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
    • Development of Legalized Channel for Organ Donors and Transplants
  • Market Restraints
    • Shortage of Organ Donors and High Cost of Treatment
  • Market Opportunities
    • Technological Advancement in Organ Transplantation Methods
    • Increasing Awareness of Organ Donation
  • Market Challenges
    • Social and Ethical Concerns in Organ Transplantation

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplantation Market

A detailed market share analysis in the Organ Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include Illumina, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Artivion, Inc., Thermo Fisher Scientific Inc., Pfizer Inc., OrganOx Limited, Organovo Holdings, Inc., Arthrex, Inc., 21st Century Medicine, Exactech, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Xvivo Perfusion AB, Sanofi S.A., BiolifeSolutions, Inc., Dr. Franz Kohler Chemie GmbH, Teva Pharmaceuticals Industries Ltd., Preservation Solutions, Inc., F. Hoffmann-La Roche Ltd, Organ Recovery Systems, Medtronic PLC, Astellas Pharma Inc., Stryker Corporation, Novartis AG, NHS Blood and Transplant, TransMedics Group, Inc., Plexision, AbbVie Inc., and Bio-Rad Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.
  • Based on End User, market is studied across Hospitals & Care Providers and Transplant Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
      • 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
      • 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancement in Organ Transplantation Methods
      • 5.1.3.2. Increasing Awareness of Organ Donation
    • 5.1.4. Challenges
      • 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
    • 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Organ Transplantation Market, by Type

  • 6.1. Introduction
  • 6.2. Heart Transplantation
  • 6.3. Kidney Transplantation
  • 6.4. Liver Transplantation
  • 6.5. Lung Transplantation
  • 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

  • 7.1. Introduction
  • 7.2. Hospitals & Care Providers
  • 7.3. Transplant Centers

8. Americas Organ Transplantation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Organ Transplantation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
    • 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
    • 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

Companies Mentioned

  • 1. Illumina, Inc.
  • 2. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • 3. Artivion, Inc.
  • 4. Thermo Fisher Scientific Inc.
  • 5. Pfizer Inc.
  • 6. OrganOx Limited
  • 7. Organovo Holdings, Inc.
  • 8. Arthrex, Inc.
  • 9. 21st Century Medicine
  • 10. Exactech, Inc.
  • 11. CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC
  • 12. Xvivo Perfusion AB
  • 13. Sanofi S.A.
  • 14. BiolifeSolutions, Inc.
  • 15. Dr. Franz Kohler Chemie GmbH
  • 16. Teva Pharmaceuticals Industries Ltd.
  • 17. Preservation Solutions, Inc.
  • 18. F. Hoffmann-La Roche Ltd
  • 19. Organ Recovery Systems
  • 20. Medtronic PLC
  • 21. Astellas Pharma Inc.
  • 22. Stryker Corporation
  • 23. Novartis AG
  • 24. NHS Blood and Transplant
  • 25. TransMedics Group, Inc.
  • 26. Plexision
  • 27. AbbVie Inc.
  • 28. Bio-Rad Laboratories, Inc.

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. ORGAN TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023